Jiang, Y., Zheng, R., & Sang, H. (2021). Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Jiang, Yaohui, Rujie Zheng, et Haiqiang Sang. Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Jiang, Yaohui, et al. Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.